Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
- Status
- RECRUITING
- Phase
- PHASE1
Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for CD19-positive ALL
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation
- Status
- COMPLETED
- Phase
- PHASE3
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
- Status
- RECRUITING
- Phase
- PHASE2
A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Stem Cell Transplantation in Crohn's Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2